Acadia Pharmaceuticals buy Morgan Stanley
Start price
18.03.24
/
50%
€17.30
Target price
18.03.25
€27.59
Performance (%)
-8.24%
End price
19.03.25
€15.88
Summary
This prediction ended on 19.03.25 with a price of €15.88. With a performance of -8.24%, the BUY prediction by Morgan_Stanley finished with a loss. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -1.867% | -1.867% | 40.565% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Morgan Stanley from $40.00 to $30.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.27
12.07.24
12.07.24
€25.68
12.07.25
12.07.25
9.19%
13.07.25
13.07.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
19.12.23
19.12.23
€36.48
19.12.24
19.12.24
-41.15%
20.12.24
20.12.24

